Episurf Medical
Pål Ryfors appointed interim CFO of Episurf Medical
REG
Episurf Medical AB (publ) announces that the company’s CEO, Pål Ryfors, has been appointed interim CFO as of 19 May 2025 in addition to his current role as CEO. This follows the departure of Veronica Wallin from her position as CFO, as previously communicated. The recruitment process for a new CFO is ongoing.
Datum | 2025-05-16, kl 10:00 |
Källa | Cision |

CFD är komplexa instrument och har en hög risk att förlora pengar snabbt på grund av hävstång. 77% av icke-professionella kunder förlorar pengar när de handlar med CFD med denna leverantör.